Results 241 to 250 of about 213,021 (351)

Scalable Perovskite Quantum Dot Glass Nanocomposites for High‐Efficiency Luminescent Solar Concentrators

open access: yesAdvanced Functional Materials, EarlyView.
This study evaluates the scalability of PQD GNC‐based LSCs for BIPV applications. Experimental data and Monte Carlo simulations predict performance up to 1 m2, achieving a peak power conversion efficiency of 3.17%. The results confirm the viability of these LSCs for energy‐efficient building applications.
Emre İlter   +6 more
wiley   +1 more source

Demonstration of an All‐Optical AND Gate Mediated by Photochromic Molecules

open access: yesAdvanced Functional Materials, EarlyView.
A logic AND gate that runs on photons is demonstrated. It relies on two spatially separated photochromic molecules that work in tandem. Abstract The realization of a photonic logic AND gate, i.e. a logic AND gate that runs on photons rather than electrons, and where all steps are controlled by light, is demonstrated. In a proof‐of‐principle experiment,
Heyou Zhang   +7 more
wiley   +1 more source

A novel class of polymeric fluorescent dyes assembled using a DNA synthesizer. [PDF]

open access: yesPLoS One, 2020
Matray T   +7 more
europepmc   +1 more source

Use of fluorescent Ca2+ dyes with green fluorescent protein and its variants: problems and solutions [PDF]

open access: green, 2001
Stephen R. Bolsover   +4 more
openalex   +1 more source

Microbubble‐Controlled Delivery of Biofilm‐Targeting Nanoparticles to Treat MRSA Infection

open access: yesAdvanced Functional Materials, EarlyView.
Here, an effective strategy using microbubble (MB)‐controlled delivery of biofilm‐targeting nanoparticles (BTNs) for removal and therapy of methicillin‐resistant Staphylococcus aureus (MRSA) biofilm infections is introduced. In vivo delivery of MB with BTN is demonstrated to silence key bacterial genes involved in biofilm formation (icaA), bacterial ...
Ju Yeon Chung   +6 more
wiley   +1 more source

Antibody‐Programmable Bimetallic Nanozymes for Transcriptional Blockade Therapy in HER2/ER‐Positive Breast Cancer

open access: yesAdvanced Functional Materials, EarlyView.
Zr‐Fe MOF@Ribociclib@Herceptin (ZFRH) efficiently targets/kills Human Epidermal Growth Factor Receptor 2/Estrogen Receptor‐positive (HER2/ER+) breast cancer cells. It combats tumors by: 1) Elevating ROS, altering redox balance; 2) Inhibiting transcription; 3) Inducing pyroptosis.
Hongkun Miao   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy